BOE Importance: 3/10

MUGEJU creates its own committees to authorize growth hormone treatments and proton therapy

18 Sep 2026 Effective: 18 Sep 2026 7 views
Who is affected:
MUGEJU members (personnel serving the Administration of Justice) and contracted insurance entities

Summary

The General Judicial Mutual creates two medical committees to evaluate and authorize growth hormone and proton therapy treatments for its members.

Detailed analysis PRO

The Orden PJC/972/2026 regulates the creation of two collegial bodies within MUGEJU: the Advisory Committee for the Assessment of Growth Hormone Treatments and the Interdisciplinary Committee for the Assessment of Proton Therapy Treatments. The first arises following the termination of the agreement with the Ministry o…

PRO exclusive content

Implicaciones prácticas, plazos y recomendaciones específicas para tu sector.

Desbloquear análisis PRO Ver planes y precios

Full official title

Orden PJC/972/2026, de 14 de septiembre, por la que se regulan el Comité Asesor para la Valoración de Tratamientos con Hormona de Crecimiento y Sustancias relacionadas y el Comité Interdisciplinar de Valoración de Tratamientos de Protonterapia para el colectivo de mutualistas adscrito a entidades de seguro concertadas y se establecen su composición y funciones dentro del organismo autónomo Mutualidad General Judicial.

Related regulations